Question 1

How many shares of TGTX does UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC own?

Accepted Answer

As of 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 249,256 shares of TGTX (TG Therapeutics, Inc.).

Question 2

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's TGTX position worth?

Accepted Answer

As of 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's TGTX position is worth $13.7M.

Question 3

Is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC buying or selling TGTX?

Accepted Answer

In 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased their TGTX position (+5.8% change in shares).

Question 4

When did UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC first buy TGTX?

Accepted Answer

Based on available 13F filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC first reported a position in TGTX in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	249,256	+5.8%	$13.7M	0.0%	$54.94	30
2026-Q1	Decreased	235,477	-1.3%	$7.8M	0.0%	$28.88	0
2025-Q4	Decreased	238,686	-2.6%	$7.1M	0.0%	$29.75	0
2025-Q3	Decreased	245,051	-40.1%	$8.9M	0.0%	$36.83	0
2025-Q2	Increased	409,393	+42.6%	$14.7M	0.0%	$36.72	38
2025-Q1	Increased	287,059	+5.4%	$11.3M	0.0%	$39.86	29
2024-Q4	Decreased	272,370	-7.3%	$8.2M	0.0%	$31.44	0
2024-Q3	Decreased	293,927	-8.7%	$6.9M	0.0%	$23.83	0